相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Suppression of ovarian cancer by low-intensity ultrasound through depletion of IL-6/STAT3 inflammatory pathway-maintained cancer stemness
Ting Gong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
Zhenru Xu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer
Hassan Yousefi et al.
TUMORI JOURNAL (2019)
IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer
Hassan Yousefi et al.
TUMORI JOURNAL (2019)
A feed-forward loop between nuclear translocation of CXCR4 and HIF-1α promotes renal cell carcinoma metastasis
Yi Bao et al.
ONCOGENE (2019)
Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
In-Hye Ham et al.
MOLECULAR CANCER (2019)
Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells
Carolina Mendez-Blanco et al.
CANCERS (2019)
Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α
Ke Wang et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2018)
Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension
Soni Savai Pullamsetti et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer
Marcela Moises Maluf Sanguinete et al.
IMMUNOLOGICAL INVESTIGATIONS (2017)
Epidemiology of ovarian cancer: a review
Brett M. Reid et al.
CANCER BIOLOGY & MEDICINE (2017)
Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression
Jie Qin et al.
SCIENTIFIC REPORTS (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Role of interleukin-6 in cancer progression and therapeutic resistance
Neeraj Kumari et al.
TUMOR BIOLOGY (2016)
Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro
Soochi Kim et al.
ONCOTARGET (2016)
Classic IL-6R signalling is dispensable for intestinal epithelial proliferation and repair
K. Aden et al.
ONCOGENESIS (2016)
OVARIAN CANCER: BEYOND RESISTANCE
David Holmes
NATURE (2015)
Anti-proliferative action of IL-6R-targeted antibody tocilizumab for non-small cell lung cancer cells
Na-Hyun Kim et al.
ONCOLOGY LETTERS (2015)
Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
Ho-June Lee et al.
CANCER CELL (2014)
HIF-1 Signaling in Drug Resistance to Chemotherapy
N. A. Warfel et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Pathological and prognostic significance of hypoxia-inducible factor 1α expression in epithelial ovarian cancer: a meta-analysis
Yue Jin et al.
TUMOR BIOLOGY (2014)
Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer
M. C. A. Wouters et al.
ONCOIMMUNOLOGY (2014)
Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
Eveline M. Dijkgraaf et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
Michael S. Anglesio et al.
CLINICAL CANCER RESEARCH (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
Yue Wang et al.
CANCER LETTERS (2010)
Quantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1 alpha Signaling Network: An Initial Study in GSC11 Glioblastoma Stem Cells
Carol L. Nilsson et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship?
Bharat B. Aggarwal et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Towards Understanding the Role of Cancer-Associated Inflammation in Chemoresistance
Karin E. de Visser et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3
Karuppaiyah Selvendiran et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma
James A. Bonner et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study
Alexandros Daponte et al.
BMC CANCER (2008)
Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1α RNA expression in both tumor cells and tumor-associated myeloid cells
Guilian Niu et al.
MOLECULAR CANCER RESEARCH (2008)
Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance
Nadine N. Bewry et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer
Lili Liu et al.
CANCER SCIENCE (2008)
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
Sizhi Paul Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1α autocrine loop, and reduces orthotopic tumor growth
Sven A. Lang et al.
CLINICAL CANCER RESEARCH (2007)
Expression of hypoxia-inducible factor 1α, hypoxia-inducible factor 2α, and von Hippel-Lindau protein in epitheLiaL ovarian neoplasms and allelic loss of von Hippel-Lindau gene:: nuclear expression of hypoxia-inducible factor 1α is an independent prognostic factor in ovarian carcinoma
Ryosuke Osada et al.
HUMAN PATHOLOGY (2007)
Role of hypoxia-inducible factor-α in hepatitis-B-virus X protein-mediated MDR1 activation
Hyo-Kyung Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Hypoxia, gene expression, and metastasis
Denise A. Chan et al.
CANCER AND METASTASIS REVIEWS (2007)
STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells
JE Jung et al.
FASEB JOURNAL (2005)
The role of hypoxia-induced factors in tumor progression
P Vaupel
ONCOLOGIST (2004)
分享论文
